Copyright Reports & Markets. All rights reserved.

Global Liquid Biopsy IVD Market Growth (Status and Outlook) 2021-2026

Request for Sample of this report
Buy now

1 Scope of the Report

  • 1.1 Market Introduction
  • 1.2 Years Considered
  • 1.3 Research Objectives
  • 1.4 Market Research Methodology
  • 1.5 Research Process and Data Source
  • 1.6 Economic Indicators
  • 1.7 Currency Considered

2 Executive Summary

  • 2.1 World Market Overview
    • 2.1.1 Global Liquid Biopsy IVD Market Size 2016-2026
    • 2.1.2 Liquid Biopsy IVD Market Size CAGR by Region 2020 VS 2021 VS 2026
  • 2.2 Liquid Biopsy IVD Segment by Type
    • 2.2.1 Circulating Tumor Cells
    • 2.2.2 Circulating Tumor Cells
    • 2.2.3 Extracellular Vesicles
    • 2.2.4 Others
  • 2.3 Liquid Biopsy IVD Market Size by Type
    • 2.3.1 Global Liquid Biopsy IVD Market Size CAGR by Type
    • 2.3.2 Global Liquid Biopsy IVD Market Size Market Share by Type (2016-2021)
  • 2.4 Liquid Biopsy IVD Segment by Application
    • 2.4.1 Blood Sample Based
    • 2.4.2 Urine Sample Based
    • 2.4.3 Other Bio Fluids Based
  • 2.5 Liquid Biopsy IVD Market Size by Application
    • 2.5.1 Global Liquid Biopsy IVD Market Size CAGR by Application
    • 2.5.2 Global Liquid Biopsy IVD Market Size Market Share by Application (2016-2021)

3 Liquid Biopsy IVD Market Size by Players

  • 3.1 Liquid Biopsy IVD Market Size Market Share by Players
    • 3.1.1 Global Liquid Biopsy IVD Revenue by Players (2019-2021E)
    • 3.1.2 Global Liquid Biopsy IVD Revenue Market Share by Players (2019-2021E)
  • 3.2 Global Liquid Biopsy IVD Key Players Head office and Products Offered
  • 3.3 Market Concentration Rate Analysis
    • 3.3.1 Competition Landscape Analysis
    • 3.3.2 Concentration Ratio (CR3, CR5 and CR10) (2019-2021E)
  • 3.4 New Products and Potential Entrants
  • 3.5 Mergers & Acquisitions, Expansion

4 Liquid Biopsy IVD by Regions

  • 4.1 Liquid Biopsy IVD Market Size by Regions (2016-2021)
  • 4.2 Americas Liquid Biopsy IVD Market Size Growth (2016-2021)
  • 4.3 APAC Liquid Biopsy IVD Market Size Growth (2016-2021)
  • 4.4 Europe Liquid Biopsy IVD Market Size Growth (2016-2021)
  • 4.5 Middle East & Africa Liquid Biopsy IVD Market Size Growth (2016-2021)

5 Americas

  • 5.1 Americas Liquid Biopsy IVD Market Size by Country (2016-2021)
  • 5.2 Americas Liquid Biopsy IVD Market Size by Type (2016-2021)
  • 5.3 Americas Liquid Biopsy IVD Market Size by Application (2016-2021)
  • 5.4 United States
  • 5.5 Canada
  • 5.6 Mexico
  • 5.7 Brazil

6 APAC

  • 6.1 APAC Liquid Biopsy IVD Market Size by Region (2016-2021)
  • 6.2 APAC Liquid Biopsy IVD Market Size by Type (2016-2021)
  • 6.3 APAC Liquid Biopsy IVD Market Size by Application (2016-2021)
  • 6.4 China
  • 6.5 Japan
  • 6.6 Korea
  • 6.7 Southeast Asia
  • 6.8 India
  • 6.9 Australia

7 Europe

  • 7.1 Europe Liquid Biopsy IVD by Country (2016-2021)
  • 7.2 Europe Liquid Biopsy IVD Market Size by Type (2016-2021)
  • 7.3 Europe Liquid Biopsy IVD Market Size by Application (2016-2021)
  • 7.4 Germany
  • 7.5 France
  • 7.6 UK
  • 7.7 Italy
  • 7.8 Russia

8 Middle East & Africa

  • 8.1 Middle East & Africa Liquid Biopsy IVD by Region (2016-2021)
  • 8.2 Middle East & Africa Liquid Biopsy IVD Market Size by Type (2016-2021)
  • 8.3 Middle East & Africa Liquid Biopsy IVD Market Size by Application (2016-2021)
  • 8.4 Egypt
  • 8.5 South Africa
  • 8.6 Israel
  • 8.7 Turkey
  • 8.8 GCC Countries

9 Market Drivers, Challenges and Trends

  • 9.1 Market Drivers and Impact
    • 9.1.1 Growing Demand from Key Regions
    • 9.1.2 Growing Demand from Key Applications and Potential Industries
  • 9.2 Market Challenges and Impact
  • 9.3 Market Trends

10 Global Liquid Biopsy IVD Market Forecast

  • 10.1 Global Liquid Biopsy IVD Forecast by Regions (2021-2026)
    • 10.1.1 Global Liquid Biopsy IVD Forecast by Regions (2021-2026)
    • 10.1.2 Americas Liquid Biopsy IVD Forecast
    • 10.1.3 APAC Liquid Biopsy IVD Forecast
    • 10.1.4 Europe Liquid Biopsy IVD Forecast
    • 10.1.5 Middle East & Africa Liquid Biopsy IVD Forecast
  • 10.2 Americas Liquid Biopsy IVD Forecast by Countries (2021-2026)
    • 10.2.1 United States Liquid Biopsy IVD Market Forecast
    • 10.2.2 Canada Liquid Biopsy IVD Market Forecast
    • 10.2.3 Mexico Liquid Biopsy IVD Market Forecast
    • 10.2.4 Brazil Liquid Biopsy IVD Market Forecast
  • 10.3 APAC Liquid Biopsy IVD Forecast by Region (2021-2026)
    • 10.3.1 China Liquid Biopsy IVD Market Forecast
    • 10.3.2 Japan Liquid Biopsy IVD Market Forecast
    • 10.3.3 Korea Liquid Biopsy IVD Market Forecast
    • 10.3.4 Southeast Asia Liquid Biopsy IVD Market Forecast
    • 10.3.5 India Liquid Biopsy IVD Market Forecast
    • 10.3.6 Australia Liquid Biopsy IVD Market Forecast
  • 10.4 Europe Liquid Biopsy IVD Forecast by Country (2021-2026)
    • 10.4.1 Germany Liquid Biopsy IVD Market Forecast
    • 10.4.2 France Liquid Biopsy IVD Market Forecast
    • 10.4.3 UK Liquid Biopsy IVD Market Forecast
    • 10.4.4 Italy Liquid Biopsy IVD Market Forecast
    • 10.4.5 Russia Liquid Biopsy IVD Market Forecast
  • 10.5 Middle East & Africa Liquid Biopsy IVD Forecast by Region (2021-2026)
    • 10.5.1 Egypt Liquid Biopsy IVD Market Forecast
    • 10.5.2 South Africa Liquid Biopsy IVD Market Forecast
    • 10.5.3 Israel Liquid Biopsy IVD Market Forecast
    • 10.5.4 Turkey Liquid Biopsy IVD Market Forecast
    • 10.5.5 GCC Countries Liquid Biopsy IVD Market Forecast
  • 10.6 Global Liquid Biopsy IVD Forecast by Type (2021-2026)
  • 10.7 Global Liquid Biopsy IVD Forecast by Application (2021-2026)

11 Key Players Analysis

  • 11.1 Bio-Rad
    • 11.1.1 Bio-Rad Company Information
    • 11.1.2 Bio-Rad Liquid Biopsy IVD Product Offered
    • 11.1.3 Bio-Rad Liquid Biopsy IVD Revenue, Gross Margin and Market Share (2019-2021)
    • 11.1.4 Bio-Rad Main Business Overview
    • 11.1.5 Bio-Rad Latest Developments
  • 11.2 Roche
    • 11.2.1 Roche Company Information
    • 11.2.2 Roche Liquid Biopsy IVD Product Offered
    • 11.2.3 Roche Liquid Biopsy IVD Revenue, Gross Margin and Market Share (2019-2021)
    • 11.2.4 Roche Main Business Overview
    • 11.2.5 Roche Latest Developments
  • 11.3 Biocartis
    • 11.3.1 Biocartis Company Information
    • 11.3.2 Biocartis Liquid Biopsy IVD Product Offered
    • 11.3.3 Biocartis Liquid Biopsy IVD Revenue, Gross Margin and Market Share (2019-2021)
    • 11.3.4 Biocartis Main Business Overview
    • 11.3.5 Biocartis Latest Developments
  • 11.4 Qiagen
    • 11.4.1 Qiagen Company Information
    • 11.4.2 Qiagen Liquid Biopsy IVD Product Offered
    • 11.4.3 Qiagen Liquid Biopsy IVD Revenue, Gross Margin and Market Share (2019-2021)
    • 11.4.4 Qiagen Main Business Overview
    • 11.4.5 Qiagen Latest Developments
  • 11.5 Guardant Health
    • 11.5.1 Guardant Health Company Information
    • 11.5.2 Guardant Health Liquid Biopsy IVD Product Offered
    • 11.5.3 Guardant Health Liquid Biopsy IVD Revenue, Gross Margin and Market Share (2019-2021)
    • 11.5.4 Guardant Health Main Business Overview
    • 11.5.5 Guardant Health Latest Developments
  • 11.6 MDxHealth
    • 11.6.1 MDxHealth Company Information
    • 11.6.2 MDxHealth Liquid Biopsy IVD Product Offered
    • 11.6.3 MDxHealth Liquid Biopsy IVD Revenue, Gross Margin and Market Share (2019-2021)
    • 11.6.4 MDxHealth Main Business Overview
    • 11.6.5 MDxHealth Latest Developments
  • 11.7 OME Care
    • 11.7.1 OME Care Company Information
    • 11.7.2 OME Care Liquid Biopsy IVD Product Offered
    • 11.7.3 OME Care Liquid Biopsy IVD Revenue, Gross Margin and Market Share (2019-2021)
    • 11.7.4 OME Care Main Business Overview
    • 11.7.5 OME Care Latest Developments
  • 11.8 NeoGenomics Laboraories
    • 11.8.1 NeoGenomics Laboraories Company Information
    • 11.8.2 NeoGenomics Laboraories Liquid Biopsy IVD Product Offered
    • 11.8.3 NeoGenomics Laboraories Liquid Biopsy IVD Revenue, Gross Margin and Market Share (2019-2021)
    • 11.8.4 NeoGenomics Laboraories Main Business Overview
    • 11.8.5 NeoGenomics Laboraories Latest Developments
  • 11.9 Sysmex Inostics
    • 11.9.1 Sysmex Inostics Company Information
    • 11.9.2 Sysmex Inostics Liquid Biopsy IVD Product Offered
    • 11.9.3 Sysmex Inostics Liquid Biopsy IVD Revenue, Gross Margin and Market Share (2019-2021)
    • 11.9.4 Sysmex Inostics Main Business Overview
    • 11.9.5 Sysmex Inostics Latest Developments
  • 11.10 Menarini Silicon Biosystems
    • 11.10.1 Menarini Silicon Biosystems Company Information
    • 11.10.2 Menarini Silicon Biosystems Liquid Biopsy IVD Product Offered
    • 11.10.3 Menarini Silicon Biosystems Liquid Biopsy IVD Revenue, Gross Margin and Market Share (2019-2021)
    • 11.10.4 Menarini Silicon Biosystems Main Business Overview
    • 11.10.5 Menarini Silicon Biosystems Latest Developments

11. Adaptive Biotechnologies

  • 11.11.1 Adaptive Biotechnologies Company Information
  • 11.11.2 Adaptive Biotechnologies Liquid Biopsy IVD Product Offered
  • 11.11.3 Adaptive Biotechnologies Liquid Biopsy IVD Revenue, Gross Margin and Market Share (2019-2021)
  • 11.11.4 Adaptive Biotechnologies Main Business Overview
  • 11.11.5 Adaptive Biotechnologies Latest Developments
  • 11.12 Biocept
    • 11.12.1 Biocept Company Information
    • 11.12.2 Biocept Liquid Biopsy IVD Product Offered
    • 11.12.3 Biocept Liquid Biopsy IVD Revenue, Gross Margin and Market Share (2019-2021)
    • 11.12.4 Biocept Main Business Overview
    • 11.12.5 Biocept Latest Developments
  • 11.13 Angle plc
    • 11.13.1 Angle plc Company Information
    • 11.13.2 Angle plc Liquid Biopsy IVD Product Offered
    • 11.13.3 Angle plc Liquid Biopsy IVD Revenue, Gross Margin and Market Share (2019-2021)
    • 11.13.4 Angle plc Main Business Overview
    • 11.13.5 Angle plc Latest Developments

    • 12 Research Findings and Conclusion

    According to this latest study, the 2021 growth of Liquid Biopsy IVD will have significant change from previous year. By the most conservative estimates of global Liquid Biopsy IVD market size (most likely outcome) will be a year-over-year revenue growth rate of XX% in 2021, from US$ xx million in 2020. Over the next five years the Liquid Biopsy IVD market will register a xx% CAGR in terms of revenue, the global market size will reach US$ xx million by 2026.

    This report presents a comprehensive overview, market shares, and growth opportunities of Liquid Biopsy IVD market by product type, application, key players and key regions and countries.

    Segmentation by type: breakdown data from 2016 to 2021 in Section 2.3; and forecast to 2026 in section 10.7.
    Circulating Tumor Cells
    Circulating Tumor DNA
    Extracellular Vesicles
    Others

    Segmentation by application: breakdown data from 2016 to 2021, in Section 2.4; and forecast to 2026 in section 10.8.
    Blood Sample Based
    Urine Sample Based
    Other Bio Fluids Based

    This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
    Americas
    United States
    Canada
    Mexico
    Brazil
    APAC
    China
    Japan
    Korea
    Southeast Asia
    India
    Australia
    Europe
    Germany
    France
    UK
    Italy
    Russia
    Middle East & Africa
    Egypt
    South Africa
    Israel
    Turkey
    GCC Countries

    The report also presents the market competition landscape and a corresponding detailed analysis of the major players in the market. The key players covered in this report: Breakdown data in in Chapter 3.
    Bio-Rad
    Roche
    Biocartis
    Qiagen
    Guardant Health
    MDxHealth
    OME Care
    NeoGenomics Laboraories
    Sysmex Inostics
    Menarini Silicon Biosystems
    Adaptive Biotechnologies
    Biocept
    Angle plc
    Buy now